Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin

Journal of Controlled Release

Volumn 61, Issue 3, 1999, Pages 305-317

  Ertl, Bernhard ^a   Platzer, Peter ^a   Wirth, Michael ^a   Gabor, Franz ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Camptothecin; Chemotherapy; Microencapsulation; Poly(D,L lactic co glycolic acid)

Indexed keywords

CAMPTOTHECIN; HYDROXYPROPYLMETHYLCELLULOSE; MICROSPHERE; POLYGLACTIN;

ARTICLE; CHEMOTHERAPY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DETERMINATION; ENCAPSULATION; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LASER MICROSCOPY; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOCOMPATIBLE MATERIALS; CAMPTOTHECIN; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; KINETICS; LACTIC ACID; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS;

EID: 0032854485     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00122-4     Document Type: Article

References (20)

1. Wall M.E., Wani M.C., Cook C.E., Palmer K.H., McPhail A.T., Sim G.A. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J. Am. Chem. Soc. 88:1966;3888-3890.
2. O'Leary J., Muggia F.M. Camptothecins: a review of their development and schedules of administration. Eur. J. Cancer. 34:(10):1998;1500-1508.
3. Slichenmyer W.J., Rowinsky E.K., Donehower R.C., Kaufmann S.H. The current status of camptothecin analogues as antitumor agents. J. Natl. Cancer Inst. 85:1993;271-291.
4. Giovanella B.C., Stehlin J.S., Wall M.E., Wani M.C., Nicholas A.W., Liu L.F., Silber R., Potmesil M. DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts. Science. 246:1989;1046-1048.
5. Conover C.D., Pendri A., Lee C., Gilbert C.W., Shum K.L., Greenwald R.B. Camptothecin delivery systems: The antitumor activity of a camptothecin-20-O-polyethylene glycol ester transport form. Anticancer Res. 17:1997;3361-3368.
6. Conover C.D., Greenwald R.B., Pendri A., Gilbert C.W., Shum K.L. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker. Cancer Chemother. Pharmacol. 42:1998;407-414.
7. Langer R. New methods in drug delivery. Science. 249:1990;1527-1533.
8. Ignatius A.A., Claes L.E. In vitro biocompatibility of bioresorbable polymers: poly(L,DL-lactide) and poly(L-lactide-co-glycolide). Biomaterials. 17:1996;831-839.
9. Schwendeman S.P., Cardamone M., Klibanov A., Langer R. Cohen S., Bernstein H. Microparticulate Systems for the Delivery of Proteins and Vaccines. 1996;1-49 Marcel Dekker, New York.
10. Shenderova A., Burke T.G., Schwendeman S.P. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vesicles. Pharm. Res. 14:1997;1406-1414.
11. Bodmeier R., Chen H. The preparation and characterization of microspheres containing the antiinflammatory agents indomethacin, ibuprofen and ketoprofen. J. Control. Release. 10:1989;167-175.
12. Gabor F., Ertl B., Wirth M., Mallinger R. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J. Microencapsulation. 16:1999;1-12.
13. Lown J.W., Chen H.H. Studies on the effects of the antitumor agent camptothecin and derivatives on deoxyribonucleic acid. Mechanism of the scission of deoxyribonucleic acid by photoactivated camptothecin. Biochem. Pharmacol. 29:1980;905-915.
14. Kingsbury W.D. The chemical rearrangement of camptothecin to mappicine ketone. Tetrahedron Lett. 29:1988;6847-6850.
15. Fortunak J.M.D., Mastrocola A.R., Mellinger M., Wood J.L. Preparation of mappicine ketones from camptothecins: chemistry of the camptothecin E ring. Tetrahedron Lett. 35:1994;5763-5764.
16. Burke T.G., Mi Z. Preferential binding of carboxylate-form of camptothecin by human serum albumin. Anal. Biochem. 22:1993;285-287.
17. Slade L., Levine H. Beyond water activity: recent advances based on an alternative approach to the assessment of food quality and safety. Crit. Rev. Food Sci. Nutr. 30:1991;115-360.
18. Burke T.G., Mishra A.K., Wani M.C., Wall M.E. Lipid bilayer partitioning and stability of camptothecin drugs. Biochemistry. 32:1993;5352-5364.
19. Spenlehauer G., Veillard M., Benoit J.P. Formation and characterization of cisplatin loaded poly(D,L-lactide) microspheres for chemoembolization. J. Pharm. Sci. 75:1986;750-755.
20. Gupta P.K., Hung C.T., Lam F.C. Rolland A. Pharmaceutical Particulate Carriers: Therapeutic Applications. 1993;135-165 Marcel Dekker, New York.